{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:29:04Z","timestamp":1793042944331,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,24]],"date-time":"2017-03-24T00:00:00Z","timestamp":1490313600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute of Dental"},{"name":"Craniofacial Research Small Business Innovation Research","award":["1R43 DE024032-01"],"award-info":[{"award-number":["1R43 DE024032-01"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biotechnology Reports"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.btre.2017.05.002","type":"journal-article","created":{"date-parts":[[2017,5,16]],"date-time":"2017-05-16T23:45:48Z","timestamp":1494978348000},"page":"24-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Dusquetide: Reduction in oral mucositis associated with enduring ancillary benefits in tumor resolution and decreased mortality in head and neck cancer patients"],"prefix":"10.1016","volume":"15","author":[{"given":"Mahesh","family":"Kudrimoti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amarinthia","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar","family":"Azawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Worden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanford","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Adkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Bonomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zack","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Elder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen T.","family":"Sonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Straube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oreola","family":"Donini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.btre.2017.05.002_bib0005","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jbiotec.2016.10.010","article-title":"Dusquetide A novel innate defense regulator demonstrating a significant and consistent reduction in the duration of oral mucositis in preclinical data and a randomized, placebo-controlled phase 2a clinical study","volume":"239","author":"Kudrimoti","year":"2016","journal-title":"J. Biotechnol."},{"issue":"11","key":"10.1016\/j.btre.2017.05.002_bib0010","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1007\/s00520-015-2688-7","article-title":"Palifermin for prevention of oral mucositis in allogeneic hematopoietic stem cell transplantation: a single-institution retrospective evaluation","volume":"23","author":"Nguyen","year":"2015","journal-title":"Support. Care Cancer"},{"issue":"1","key":"10.1016\/j.btre.2017.05.002_bib0015","first-page":"43","article-title":"Reliability and efficacy of palifermin in prevention and management of oral mucositis in patients with acute lymphoblastic leukemia: a randomized, double-blind controlled clinical trial","volume":"65","author":"Lucchese","year":"2016","journal-title":"Minerva Stomatol."},{"issue":"1","key":"10.1016\/j.btre.2017.05.002_bib0020","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1345\/aph.1G473","article-title":"Palifermin: role in the prevention of chemotherapy- and radiation-induced mucositis","volume":"41","author":"McDonnell","year":"2007","journal-title":"Ann. Pharmacother."},{"issue":"20","key":"10.1016\/j.btre.2017.05.002_bib0025","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1200\/JCO.2010.32.4103","article-title":"Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial","volume":"29","author":"Henke","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.btre.2017.05.002_bib0030","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1200\/JCO.2011.39.1136","article-title":"Palifermin in prevention of head and neck cancer radiation-induced mucositis: not yet a definitive word on safety and efficacy profile","volume":"30","author":"Bossi","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.btre.2017.05.002_bib0035","first-page":"1","article-title":"Oral mucositis prevention and management by therapeutic laser in head and neck cancers","volume":"5","author":"Fekrazad","year":"2014","journal-title":"J. Lasers Med. Sci."},{"issue":"1","key":"10.1016\/j.btre.2017.05.002_bib0040","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00520-012-1594-5","article-title":"Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients","volume":"21","author":"Raber-Durlacher","year":"2013","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.btre.2017.05.002_bib0045","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.oraloncology.2016.01.005","article-title":"Could the biological robustness of low level laser therapy (Photobiomodulation) impact its use in the management of mucositis in head and neck cancer patients","volume":"54","author":"Sonis","year":"2016","journal-title":"Oral Oncol."},{"issue":"1","key":"10.1016\/j.btre.2017.05.002_bib0050","first-page":"21","article-title":"A biological approach to mucositis","volume":"2","author":"Sonis","year":"2004","journal-title":"J. Support. Oncol."},{"key":"10.1016\/j.btre.2017.05.002_bib0055","first-page":"3","article-title":"Pathobiology of oral mucositis: novel insights and opportunities","volume":"5","author":"Sonis","year":"2007","journal-title":"J. Support. Oncol."},{"key":"10.1016\/j.btre.2017.05.002_bib0060","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.oraloncology.2006.03.014","article-title":"Gene expression changes in peripheral blood cells provide insight into the biological mechanisms associated with regimen-related toxicities in patients being treated for head and neck cancers","volume":"43","author":"Sonis","year":"2007","journal-title":"Oral Oncol."},{"key":"10.1016\/j.btre.2017.05.002_bib0065","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ctrv.2007.03.001","article-title":"The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs","volume":"33","author":"Logan","year":"2007","journal-title":"Cancer Treat. Rev."},{"issue":"52","key":"10.1016\/j.btre.2017.05.002_bib0070","doi-asserted-by":"crossref","first-page":"36007","DOI":"10.1074\/jbc.C109.073627","article-title":"Sequestosome-1\/p62 is the key intracellular target of innate defense regulator peptide","volume":"284","author":"Yu","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.btre.2017.05.002_bib0075","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jbiotec.2016.03.032","article-title":"A novel approach for emerging and antibiotic resistant infections: innate defense regulators as an agnostic therapy","volume":"226","author":"North","year":"2016","journal-title":"J. Biotechnol."},{"issue":"4","key":"10.1016\/j.btre.2017.05.002_bib0080","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nbt1288","article-title":"An anti-infective peptide that selectively modulates the innate immune response","volume":"25","author":"Scott","year":"2007","journal-title":"Nat. Biotechnol."},{"issue":"3","key":"10.1016\/j.btre.2017.05.002_bib0085","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.cell.2016.09.030","article-title":"P62 in cancer: signaling adaptor beyond autophagy","volume":"167","author":"Moscat","year":"2016","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.btre.2017.05.002_bib0090","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.phrs.2012.07.004","article-title":"p62\/SQSTM1\/A170: physiology and pathology","volume":"66","author":"Komatsu","year":"2012","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.btre.2017.05.002_bib0095","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1006\/geno.1999.5851","article-title":"Cloning and genomic organization of Beclin-1, a candidate tumor suppressor gene on chromosome 17q21","volume":"59","author":"Aita","year":"1999","journal-title":"Genomics"},{"key":"10.1016\/j.btre.2017.05.002_bib0100","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1017\/S1462399409001306","article-title":"The role of autophagy in tumour development and cancer therapy","volume":"11","author":"Rosenfeldt","year":"2009","journal-title":"Exp. Rev. Mol. Med."},{"issue":"20","key":"10.1016\/j.btre.2017.05.002_bib0105","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1182\/blood-2008-08-173948","article-title":"Increased signaling through p62 in the marrow microenvironment increases myeloma cell growth and osteoclast formation","volume":"113","author":"Hiruma","year":"2009","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.btre.2017.05.002_bib0110","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/leu.2015.229","article-title":"Blocking the ZZ domain of sequestosome1\/p62 suppresses myeloma growth and osteoclast formation in vitro and induces dramatic bone formation in myeloma-bearing bones in vivo","volume":"30","author":"Teramachi","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.btre.2017.05.002_bib0115","article-title":"SEER Cancer Statistics Review, 1975\u20132013","year":"2015"},{"issue":"2","key":"10.1016\/j.btre.2017.05.002_bib0120","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur. J. Cancer"}],"container-title":["Biotechnology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2215017X17300693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2215017X17300693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T15:51:40Z","timestamp":1535817100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2215017X17300693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":24,"alternative-id":["S2215017X17300693"],"URL":"https:\/\/doi.org\/10.1016\/j.btre.2017.05.002","relation":{},"ISSN":["2215-017X"],"issn-type":[{"value":"2215-017X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dusquetide: Reduction in oral mucositis associated with enduring ancillary benefits in tumor resolution and decreased mortality in head and neck cancer patients","name":"articletitle","label":"Article Title"},{"value":"Biotechnology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.btre.2017.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}